LABETALOL HYDROCHLORID
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
Labetalol Hydrochloride Injection USP, 5 mg per mL in 40 mL vials, is being procured under solicitation SPE2DP-26-T-4201 with a total quantity of four vials, each containing 40 mL, for delivery within five days FOB destination. The item is regulated by the FDA and carries a non-extendable shelf life of 24 months as per RS001 requirements for Type I (Code M) pharmaceuticals. Packaging must comply with MIL-STD-2073-1E and the latest Medical Marking Standard No. 1, and all supplies must be labeled with the NDC number 00143-9623-01 under Hikma Pharmaceuticals USA Inc. The contract mandates strict zero variance in quantity and requires inspection and acceptance at the destination point. Technical and quality specifications are governed by the DLA Master List of Technical and Quality Requirements, and government identification must be removed from any non-accepted supplies. The contracting official must submit an EBS referral to the product specialist with full bidder and manufacturer details prior to award. The item is authorized under the DoD unit of issue VI, and procurement is managed by the Department of Defense through the Medical Supply Chain PHARM FSA.
General Info
Agency
NAICS
Place of Performance
BLDG 1509 WEST 6TH STREET, FORT STEWART, GA, 31314-5185, USSet-Aside
Timeline
Response Deadline
Organization & Contact Information
Full Description
LABETALOL HYDROCHLORIDE INJECTION<(>,<)> USP. 5 MG PER ML<(>,<)> 40 ML.
1 VI = 40 ML. STORE AT MEDICAL CONTROLLED ROOM TEMPERATURE.
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
INCLUDE RD003 OBJECT TEXT ID ST
This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description. RS016: Shelf-life requirement RS001 for a TYPE I (CODE M) item with a shelf life of 24 months (non-extendable) applies to this item.
Shall be marked IAW the latest edition of Medical Marking Standard No. 1 https://www.dla.mil/Logistics-Operations/Packaging/
HIKMA PHARMACEUTICALS USA INC. 32655 P/N NDC00143-9623-01
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7017513543 0001 VI 4.000
NSN/MATERIAL:6505012579990
DELIVERY (IN DAYS):0005
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
SPE2DP-26-T-4201
SECTION B
PR: 7017513543 PRLI: 0001 CONT’D
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA MIL-STD-2073-1E
SPECIAL NSN/Part Number: 6505-01-257-9990 Quantity: 4 VI Purchase Request: 7017513543QTY: 4 Delivery: 5 days ADO
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Same awarding agency
